ClosetInvestor wrote: 2. The small amount of pa
Post# of 148163
2. The small amount of patients so far showing these results (only data from 7 now). I would’ve liked for NP to wait and report data on all 15 instead of only 7 (similar to filing for mTNBC BTD with data from only a handful of patients, which didn’t work).
_____________
There is a different way of looking at Nader's submissions which to us look somewhat premature. These early submissions create a papertrail of FDA's denials which one day may and will be construed as evidence for an FBI investigation or taking FDA to court. IMO.
CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.